Summary profile of Dr.K.Anand Kumar Dr. K.Anand Kumar, Ph.D D.Sc Managing Director - Indian Immunologicals Ltd (a wholly owned subsidiary of National Dairy Development Board), Hyderabad, India Director - Pristine Biologicals New Zealand Ltd. Dr. K.Anand Kumar did his Ph.D in Microbiology from Indian Council of Medical Research (ICMR) centre in Puducherry and has over 32 years of experience in the vaccine/biotechnology/pharma Industry. Dr. Kumar is currently the Managing Director at Indian Immunologicals Ltd (IIL). Indian Immunologicals Ltd is a One Health company created by National Dairy Development Board (NDDB). IIL is one of the largest producer of vaccines in Asia for humans and animals. He is a whole time Director on the board of IIL and also established a company (Pristine Biologicals) in New Zealand to secure a key raw material used in vaccine manufacturing. He has worked for more than a decade outside India for companies such as Pfizer Global Manufacturing in Australia and Schering Plough Animal Health in New Zealand. Dr.Kumar is a member of the National Biotechnology Committee with CII. He currently is on the expert panel on analytical methods related to vaccines with the Indian Pharmacopeia (IP). He served as an expert volunteer with United States Pharmacopeia (USP) during the period 2010-15. He is a speaker at various international forums including the recently conducted G20. He has visited over 50 countries. At a time of National emergency and on a call of duty by Niti Aayog he lead his team at IIL to augment Covid 19 vaccine capacity in the country by producing and supplying 30 million doses in record time. This life saving effort was lauded by the Government of India. Through active collaboration with premier institutes across the globe he lead his team to develop the world's 1st vaccine for Tape worm (Cysvax) and India’s first vaccine for Hepatitis A virus. Vaccines developed under his leadership are Pentavalent vaccine, Measles-Rubella vaccine, Hepatitis A vaccine, Tetanus-Diptheria vaccine in the human segment and Blue Tongue virus vaccine, Brucella vaccine, Classical Swine Fever vaccine, Goat pox vaccine, multivalent canine vaccine, IBR vaccine in the animal segment. He has actively also contributed to the commercialization of various recombinant biotech products including Human Insulin, Erythropoietin, Insulin Glargine, Interferon., Epidermal Growth Factor. He is listed in the top 40 influencers in the Indian biopharmaceutical industry by Terrapin, a leading consultancy firm from Singapore. He is widely acknowledged for his vision, strategy and bringing self-sufficiency to our country for both human and Animal vaccines. The affordable vaccines developed by him and his team have saved the Government and consumers several thousand crores of rupees. He is listed among the elite list of visionaries who have shaped Hyderabad as it is today by leading successful ventures (www.hyderabadstories.com/pioneers). He has won many awards, papers and patent to his credit. He has been conferred with Honorary Doctorate of Science by Saveetha institute of Medical and Technical Sciences. He has been awarded Outstanding alumnus by Indian Council Medical Research in June 2022 and awarded the distinguished alumnus by PSG Sons and Charities in Jan 2023. He received the “Vocational Excellence” award from Rotary International in 2024. He is a member of the Indian Vaccine Manufacturers Association and the Vice President at Veterinary Vaccine India Manufacturers Association.